News
Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the ...
Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...
Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...
Bausch Health Companies (BHC) and its gastroenterology business, Salix Pharmaceuticals, announced the U.S. District Court for the District of ...
Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and ...
Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of some of its intraocular lenses due to safety concerns.
Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S ...
The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety ...
NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an ...
Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company ...
Recall issued in response to reports of toxic anterior segment syndrome. HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results